Effectiveness of counseling in patients of breast and cervical cancer receiving chemotherapy and radiotherapy - prospective observational study

Authors

  • U.Srinivas Department of Pharmacy, Andhra University College of Pharmaceutical Sciences, Visakhapatnam
  • R.Sowjanya Department of Pharmacy, Andhra University College of Pharmaceutical Sciences, Visakhapatnam
  • K.Suvarnamala Department of Pharmacy, Andhra University College of Pharmaceutical Sciences, Visakhapatnam.
  • N.Sujatha Professor and Head of the Radiotherapy Department, King George Hospital, Visakhapatnam.
  • B.Veera Raghavulu Assistant Professor, Andhra University College of Pharmaceutical Sciences, Visakhapatnam

DOI:

https://doi.org/10.47957/ijpda.v10i2.514

Keywords:

EORTC QLQ – C30 (version 3) scale, chemotherapy, radiotherapy, prospective observational study, side effect management, cervical cancer,, breast cancer, chemoradiation

Abstract

Cancer is one of the main problems in the India and world also. From the world health organization report (2022), 10 million deaths in the year of 2022 of the entire world. This reflects one in six deaths. Side effects are very common in the cancer treatment process i.e. chemotherapy, radiotherapy and chemo radiation therapy. Proper knowledge is required in these aspects. Sometimes these side effects lead to life threatening due to lack of knowledge on side effects management while patients are in the home. These patients also need counseling, consultation and about side effects management of their treatment. This counselling leads to not only the patient’s quality of life but also improve the patients’ psychological conditions during their treatment process.  In our prospective observational study, the main objectives are checking the effectiveness of before counselling and after counselling with respect to patient’s side effect management and psychological effectiveness. Finally evaluate the outcome with the counselling in both breast and cervical cancer patients. We provide counseling for cancer patients in King George Hospital, Visakhapatnam, India. In our study we used EORTC QLQ – C30 (version 3) scale for comparison of with or without counseling in the areas of side effect management, effectiveness of psychological and nutritional in breast and cervical cancer patients. Finally in our study we noticed that mostly rural area and some urban people were lack of knowledge on side effect management of cancer treatment. By providing better counseling to these patients especially in rural area people for their treatment and create awareness of cancer in group counseling for care givers then automatically better side effect management was possible in cancer patients. Pharmacist counseling is one of the important services that has been associated with improved outcome.

Downloads

Download data is not yet available.

References

Sherina Mohd-Sidik, Mehrnoosh Akhtari-Zavarea, Ummavathy Periasamyd, Lekhraj Rampale , Siti Irma Fadhilahb , Rozi Mahmud, Effectiveness of chemotherapy counselling on self-esteem and psychological affects among cancer patients in Malaysia: Randomized controlled trial. PECELSEVIER 2018; 101: 862–871.

Kristin Vassbotn Guldhav, Randi Jepsen, Siri Ytrehus and Ellen Karine Grov, Access to information and counselling – older cancer patients’ self-report: a cross sectional survey. BMCN 2017; 16(18):1-11.

Indian Council of Medical Research (ICMR) cancer report published in 2016.

Huei-Ying Huang et al, Quality of life of breast and cervical cancer survivors: a cross-sectional design. ISSN 2017; 1472-6874..

Ellen Warner, C. Carroll, Ruth E. Heisey, Vivek Goel, Wendy S. Meschino, H. Lavina A. Lickley, Brian D. Doan, Pamela L. Chart, Vanessa Orr, Shelley Lothian, Educating women about breast cancer. An intervention for women with a family history of breast cancer. CFPMFC 2003; 49: 56–63.

GLOBOCAN cancer report published in 2012..

Schipper H. Quality of life: principles of the clinical paradigm. J Psychosocial Oncol. 1990;8(2–3):171–185.

De Walden-Galuszko K. Quality of life – general considerations. In: De Walden-Galuszko K, Majkowicz M, editors. Quality of Life in Cancer.Gdansk: Wydawnictwo Uniwersytetu Gdanskiego; 1994. pp. 13–40. Polish.

Moro C, Brunelli C, Miccinesi G, et al. Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer. 2006;14(1):30–37.

Strömgren AS, Goldschmidt D, Groenvold M, et al. Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer. 2002;94(2):512–520.

Velikova G, Stark, D, Selby P. Quality of life instruments in oncology. Eur J Cancer 1999;35:1571–1580.

Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997;278:47–50.

Sanders C, Egger M, Donovan J et al. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 1998;317:1191–1194.

Detmar SB, Aaronson NK. Quality of life assessment in daily clinical oncology practice: a feasibility study.Eur J Cancer 1998;34:1181–1186.

Feld R. Endpoints in cancer clinical trials: is there a need for measuring quality of life? Support Care Cancer1995;3:23–27.

Muldoon MF, Barger SD, Flory JD et al. What are quality of life measurements measuring? BMJ1998;316:542–545.

Moinpour CM. Do quality of life assessments make a difference in the evaluation of cancer treatments?Control ClinTrials 1997;18:311–317.

Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol1994;12:608–616.

Young T, Maher J. Collecting quality of life data in EORTC clinical trials—what happens in practice?Psychooncology 1999;8:260–263.

Tanaka T, Gotay CC. Physicians' and medical students' perspectives on patients' quality of life. Acad Med 1998;73:1003–1005.

Aaronson NK, Ahmedzai S, Bergman B, et al for the European Organization for Research and Treatment of Cancer. QLQ-C30: A Quality-of-Life Instrument forUse in International Clinical Trials in Oncology. JNCI 85: 365-376, 1993.

Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. JCO 11(3), 570-579, 1993.

The EuroQol Group (1990). EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16(3):199-208.

Herdman M, Gudex C, Lloyd A et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. December; 20(10): 1727–1736, 2011.

Clinical Trials in Cancer: principles and practice. Girling et al. Oxford.Websites.

Youlden DR, Cramb SM ,Yip CH , et al . Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 2014;11:10115.

Agarwal G , Pradeep PV , Aggarwal V, et al . Spectrum of breast cancer in Asian women. World J Surg 2007;31:1031–40.

Mousavi-Jarrrahi SH , Kasaeian A ,Mansori K , et al . Addressing the younger age at onset in breast cancer patients in Asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer. ISRN Oncol2013;2013:1–8.

Aubin S, Perez S. The Clinician's Toolbox: Assessing the Sexual Impacts of Cancer on Adolescents and Young Adults with Cancer (AYAC). Sex Med. 2015; 3(3): 198–212.

Division of Cancer Prevention and Control, Centers for Disease Control and Prevention. U.S. Department of Health & Human Services. 2017.

EORTC- Quality of Life. Quality of Life Department, Available at: http://groups.eortc.be/qol/quality-life

Finelli T. Men With Metastatic Prostate Cancer: It’s Not Just.

Quantity Of Life That Matters, But Quality Of Life. Personal health news. Research and Innovations. MediaPlanet 2017. Available at http://www.personalhealthnews.ca/research-and-innovations.

Harden J, Northouse L, Cimprich B, Pohl MJ, Liang J, KershawT. The Influence of Developmental Life Stage on Quality of Life In Survivors of Prostate Cancer and Their Partners. J Cancer Surviv. 2008; 2(2): 84–94.

Megari K. Quality of Life in Chronic Disease Patients. Health Psychol Res. 2013 Sep 24; 1(3): e27.

Kawaguchi T, Iwase S, Koinuma M, Onodera Y, Takeuchi H, Umeda M, Matsunaga T, Unezaki S, Nagumo Y. Determinants affecting quality of life: implications for pharmacist counseling for patients with breast cancer in Japan. Biol Pharm Bull. 2012; 35(1): 59-64.

Tadele N. Evaluation of quality of life of adult cancer patients attending tikur anbessa specialized referral hospital, Addis ababa Ethiopia. Ethiop J Health Sci. 2015; 25(1): 53-62.

Thiboldeaux K, Golant M. 2012. Reclaiming Your Life After Diagnosis: The Cancer Support Community Handbook. BenBella Books. Page 192.

Valerie F, Wendy L, Paul K. Han, Michael P. Pignone. Decision Making and Cancer. Am Psych. 2015; 70 (2): 105–118.

Wells N, Pasero C, McCaffery M. 2008. Improving the Quality of Care through Pain Assessment and Management. In: Hughes RG, editor. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Rockville (MD): Agency for Healthcare Research and Quality (US); Chapter 17.

Sunanda VN, Priyanka M, Architha J, Shravan M, Srinivasa Rao A, Hadi MA. Quality of Life Assessment in Cancer Patients of Regional Centre of Hyderabad City. J App Pharm Sci, 2018; 8 (01): 165-169.

Published

2022-07-07
Statistics
16 Views | 15 Downloads
Citatons

How to Cite

U, S., S. R, S. K, S. N, and V. R. B. “Effectiveness of Counseling in Patients of Breast and Cervical Cancer Receiving Chemotherapy and Radiotherapy - Prospective Observational Study”. International Journal of Pharmaceutics and Drug Analysis, vol. 10, no. 2, July 2022, pp. 69-77, doi:10.47957/ijpda.v10i2.514.

Issue

Section

Research Articles
Share |